中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
机构
采集方式
内容类型
发表日期
学科主题
筛选

浏览/检索结果: 共889条,第1-10条 帮助

条数/页: 排序方式:
UniPR129 is a competitive small molecule Eph-ephrin antagonist blocking in vitro angiogenesis at low micromolar concentrations Eph antagonist and angiogenesis 期刊论文  OAI收割
出版物, 3111, 期号: 0, 页码: 1-32
作者:  
I Hassan-Mohamed;  C Giorgio;  M Incerti;  S Russo;  D Pala
  |  收藏  |  浏览/下载:209/0  |  提交时间:2017/07/24
The Tyrosine Kinase Inhibitor Bafetinib Inhibits PAR2-induced Activation of TRPV4 In Vitro and Pain In Vivo1 期刊论文  OAI收割
出版物, 2111, 页码: 1-44
作者:  
1M S Grace;  T Lieu;  B Darby;  F C Abogadie;  N Veldhuis N W Bunnett;  P McIntyre
  |  收藏  |  浏览/下载:244/0  |  提交时间:2017/07/24
Bicyclic polyprenylated acylphloroglucinol-related meroterpenoids as potent DRAK2 inhibitors from Hypericum patulum 期刊论文  OAI收割
PHYTOCHEMISTRY, 2025, 卷号: 232, 页码: 10
作者:  
Huang, Jin-Chang
  |  收藏  |  浏览/下载:9/0  |  提交时间:2025/04/01
Design, Synthesis, and biological evaluation of 7H-Pyrrolo[2,3-d] pyrimidines as potent HPK1 kinase inhibitors 期刊论文  OAI收割
BIOORGANIC & MEDICINAL CHEMISTRY, 2025, 卷号: 119, 页码: 13
作者:  
Wu, Feifei;  Li, Huiyu;  Li, Weiqiang;  Zhang, Laishun;  An, Qi
  |  收藏  |  浏览/下载:4/0  |  提交时间:2025/04/01
Design, synthesis and pharmacological evaluation of 1,2,3,4-tetrahydrobenzofuro[2,3-c] pyridine derivatives as p21-activated kinase 4 inhibitors for treatment of pancreatic cancer 期刊论文  OAI收割
ACTA PHARMACEUTICA SINICA B, 2025, 卷号: 15, 期号: 1, 页码: 438-466
作者:  
Li, Yang;  Fang, Yan;  Chen, Xiaoyu;  Tong, Linjiang;  Feng, Fang
  |  收藏  |  浏览/下载:10/0  |  提交时间:2025/04/01
Integrative study of lung cancer adeno-to-squamous transition in EGFR TKI resistance identifies RAPGEF3 as a therapeutic target 期刊论文  OAI收割
NATIONAL SCIENCE REVIEW, 2024, 卷号: 11, 期号: 12, 页码: 20
作者:  
Wang, Hua;  Tang, Shijie;  Wu, Qibiao;  He, Yayi;  Zhu, Weikang
  |  收藏  |  浏览/下载:14/0  |  提交时间:2025/02/28
Synthesis and evaluation of hybrid molecules as RIPK1 and HDACs dual inhibitors 期刊论文  OAI收割
JOURNAL OF MOLECULAR STRUCTURE, 2024, 卷号: 1318, 页码: 13
作者:  
Tang, Mingze;  Zhou, Xuan;  Shen, Qianqian;  Fang, Chen;  Peng, Xia
  |  收藏  |  浏览/下载:12/0  |  提交时间:2024/08/22
Discovery of a Potent, selective and orally bioavailable CDK9 degrader for targeting transcription regulation in Triple-Negative breast cancer 期刊论文  OAI收割
BIOORGANIC CHEMISTRY, 2024, 卷号: 153, 页码: 16
作者:  
Nie, Hui-Jun;  Li, Ben-Fu;  Sun, Jingya;  Yuan, Yali;  Zhang, Zhi-Gao
  |  收藏  |  浏览/下载:9/0  |  提交时间:2024/11/26
Design and synthesis of pyridazin-4-one derivatives as necroptosis inhibitors 期刊论文  OAI收割
ARCHIV DER PHARMAZIE, 2024, 页码: 16
作者:  
An, Yuxiang;  Peng, Xia;  Wang, Tianchen;  Liu, Kaiyuan;  Feng, Dazhi
  |  收藏  |  浏览/下载:10/0  |  提交时间:2024/12/25
Comprehensive multi-omics analysis elucidates colchicine-induced toxicity mechanisms and unveils the therapeutic potential of MLN4924 and kinase inhibitors 期刊论文  OAI收割
ACTA PHARMACOLOGICA SINICA, 2024, 页码: 13
作者:  
Zhai, Lin-hui;  Jia, Xing-long;  Chen, Yu-lu;  Liu, Mu-yin;  Zhang, Jing-dan
  |  收藏  |  浏览/下载:72/0  |  提交时间:2024/12/25